Offer - Urjas Oil for just ₹ 1 X
Primacip 7.5 Mg Tablet is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Malaria. Primacip 7.5 Mg Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Primacip 7.5 Mg Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The most common side effects of Primacip 7.5 Mg Tablet are Abdominal Pain. Besides the aforementioned side effects, there are other adverse effects of Primacip 7.5 Mg Tablet as well, which are listed below. Usually, these side effects of Primacip 7.5 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Primacip 7.5 Mg Tablet's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Primacip 7.5 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
The section on Primacip 7.5 Mg Tablet contraindications lists all such conditions.
Besides this, Primacip 7.5 Mg Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Primacip 7.5 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Primacip 7.5 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Is the use of Primacip 7.5 Mg Tablet safe for pregnant women?
Primacip can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Primacip right away. Take your doctor's advice before taking it again.
Is the use of Primacip 7.5 Mg Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Primacip. If you see any side effects, stop taking Primacip immediately and talk to your doctor. Take Primacip again, only after your doctor's advice.
What is the effect of Primacip 7.5 Mg Tablet on the Kidneys?
Using Primacip does not have any harmful effects on kidneys.
What is the effect of Primacip 7.5 Mg Tablet on the Liver?
Primacip is rarely harmful for the liver.
What is the effect of Primacip 7.5 Mg Tablet on the Heart?
Very few cases of side effects of Primacip on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Primacip 7.5 Mg Tablet unless your doctor advises you to do so -
Is this Primacip 7.5 Mg Tablet habit forming or addictive?
No, there is no any evidence that Primacip 7.5 Mg Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Primacip 7.5 Mg Tablet. So it is best to avoid driving.
Is it safe?
Primacip 7.5 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Primacip 7.5 Mg Tablet is not used to treat mental disorders.
Interaction between Food and Primacip 7.5 Mg Tablet
Taking Primacip 7.5 Mg Tablet with food does not cause any problems.
Interaction between Alcohol and Primacip 7.5 Mg Tablet
Consuming Primacip 7.5 Mg Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Primaquine phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 828